Research & Studies: CBD for Heart Disease
Here is a list of research and studies on CBD and it’s potential use for treating Heart Disease.
CBD for Heart Disease:
- Is the cardiovascular system a therapeutic target for cannabidiol?
- Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
- Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
- 17 Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors
- The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
- Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
- Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
- Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
- Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
IMPORTANT: Most of these studies involve cannabinoid molecules, experimental animals, test tubes, and sometimes human cell-lined studies. It’s important to understand that the Endocannabinoid System exists in all mammals including dogs, cats, rabbits, horses, and humans. CBD affects us in the same way that it affects our pets.